SCHEMBL24752165

SCHEMBL24752165

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5cc(-c6cccc7ccccc67)cc(-n6c7ccccc7c7ccccc76)c5)c5ccccc45)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.39
▸ KMT2A Q03164 6/20 0.39
▸ MAPT P10636 5/20 0.39
▸ HPGD P15428 5/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ NTSR1 P30989 1/20 0.39
▸ TUBB4A P04350 1/20 0.38
▸ TUBB P07437 1/20 0.38
▸ TUBA3C P0DPH7 1/20 0.38
▸ TUBA1B P68363 1/20 0.38
▸ TUBA4A P68366 1/20 0.38
▸ TUBB4B P68371 1/20 0.38
▸ TUBB3 Q13509 1/20 0.38
▸ TUBB2A Q13885 1/20 0.38
▸ TUBB8 Q3ZCM7 1/20 0.38
▸ TUBA3E Q6PEY2 1/20 0.38
▸ TUBA1A Q71U36 1/20 0.38
▸ TUBA1C Q9BQE3 1/20 0.38
▸ TUBB6 Q9BUF5 1/20 0.38
▸ TUBB2B Q9BVA1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17899210 0.93 MEN1 (0.40) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL26432086 0.93 MEN1 (0.42) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL24752161 0.93 MEN1 (0.42) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL26432041 0.92 MEN1 (0.43) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL21973891 0.92 TUBB4A (0.42) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL24752158 0.92 MEN1 (0.40) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL14416359 0.91 MEN1 (0.40) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL17899218 0.91 ALDH1A1 (0.40) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL14416368 0.91 MEN1 (0.40) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL13227526 0.91 MEN1 (0.40) MEN1KMT2AMAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
EP-4101851-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2022-12-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, EPCAM, TMEM109 MEN1 1030/4885KMT2A 2821/4885MAPT 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback